Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>The FDA&rsquo;s draft guidance on the use of electronic records and electronic signatures encourages systems to improve quality and efficiency, and expands the use of a risk-based approach in validating and establishing audit trails for electronic systems. But it&rsquo;s the validation part of the proposed guidance that could introduce a new problem.</p>

FDA’s Draft Guidance on eRecords Could Have Unintended Consequences